| Field | Specification |
|---|---|
| Mfr No | |
| Activity | |
| Alternative Names | Nerve Growth Factor 2.5S, TrkA receptors |
| Cas No. | |
| Concentration | |
| Form | Lyophilized |
| Formulation | |
| Gene ID | |
| Molecular Weight | |
| Product Type | |
| Purity | |
| Reconstitution | |
| Solubility | Centrifuge the vial before adding solvent (10,000 x g for 5 minutes) to spin down all the powder to the bottom of the vial. The lyophilized product may be difficult to visualize. Add solvent directly to the centrifuged vial. Tap the vial to aid in dissolving the lyophilized product. Tilt and gently roll the liquid over the walls of the vial. Avoid vigorous vortexing. Light vortexing for up to 3 seconds is acceptable if needed. For long-term storage in solution, we recommend preparing a stock solution by dissolving the product in sterile water at a concentration of at least 0.1 mg/mL. Divide the stock solution into small aliquots and store at -20°C. Before use, thaw the relevant vial(s) and dilute to the desired working concentration in your working buffer. It is recommended to prepare fresh solutions in working buffers just before use. Repeat freeze-thawing may result in loss of activity. |
| Source | Natural protein |
| Species | |
| Storage | |
| Target |
Overview
Native mouse NGF 2.5S protein (>95%) is a research-grade protein/peptide reagent used in research settings. It is commonly applied as a tool reagent related to p75NTR, TrkA receptors biology and/or assay development. It is supplied in Lyophilized format to support flexible downstream use in RUO workflows. Researchers commonly pair it with applications such as Neurite outgrowth assay, Cell survival assay.
Key elements and design rationale
- Molecular identity: CAS: 93928-24-6, MW: 26 kDa.
- Source / origin: Native protein isolated from mouse submaxillary glands..
- Quality attributes: Purity: >95% (HPLC); Bioassay tested: Yes.
When used as a biochemical or pharmacological tool, results are best interpreted relative to the experimental system (species, expression level, and assay readout) and with appropriate negative and competition-style controls where relevant. This product is intended for research use only.
Biological background
The neurotrophins ("neuro" means nerve and "trophe" means nutrient) are a family of soluble, basic growth factors which regulate neuronal development, maintenance, survival and death in the CNS and PNS.1NGF, the first member of the family to be discovered, was originally purified as a factor able to support survival of sympathetic and sensory spinal neurons in culture.2 It is synthesized and secreted by sympathetic and sensory target organs and provides trophic support to neurons as they reach their final target.3Neurotrophin secretion increases in the nervous system following injury. Schwann cells, fibroblasts, and activated mast cells normally synthesize NGF constitutively, however direct trauma and induction of cytokines combine to increase neurotrophin production in these cells after injury.4NGF is purified in three forms: the 7S, 2.5S and β. The 7S (130 kDa) form occurs naturally in mouse submaxillary glands, and is a multimeric protein composed of two α, one β and two γ subunits. The name is derived from its sedimentation co-efficient, 7S.The biologically active subunit is the β, which is a 26 kDa dimer composed of two identical 120 amino acid chains held together by hydrophobic interactions.5 The 2.5S form is 9 amino acids shorter than the β form because of proteolysis that occurs during the purification process.6 The structural hallmark of all the neurotrophins is the characteristic arrangement of the disulfide bridges known as the cysteine knot, which has been found in other growth factors such as Platelet-derived growth factor.7 There is a 95.8% homology between the rat and mouse forms, and a 85% homology between the human and mouse.NGF has been shown to regulate neuronal survival, development, function and plasticity.8 Recently, involvement of NGF in processes not involving neuronal cells has been shown, such as asthma,9 psoriasis10 and wound healing.11 The biological effects of NGF are mediated by two receptors: TrkA, which is specific for NGF, and p75NTR, which binds all the neurotrophins.12
Research relevance and current trends
- Using high-specificity ligands, toxins, and engineered peptides to dissect closely related receptor/channel subtypes and signaling microdomains.
- Pairing labeled (e.g., fluorescent) proteins/peptides with advanced imaging to map surface expression, trafficking, and nanoscale organization.
- Increasing emphasis on reproducibility through standardized characterization (identity, purity, and lot QC) and transparent reporting of reagent attributes.
Common research applications
- Neurite outgrowth assay: commonly used to compare signal, binding, or functional readouts across conditions without implying a specific protocol.
- Cell survival assay: commonly used to compare signal, binding, or functional readouts across conditions without implying a specific protocol.
Across these use cases, changes in signal or functional readout are generally interpreted as evidence of differences in target abundance, accessibility, or engagement, but alternative explanations (matrix effects, off-target interactions, or assay artifacts) should be considered.
Notes for experimental interpretation
- Assay context matters: binding assays, functional modulation, and detection workflows can yield different readouts even for the same target system.
- Target complexity: closely related family members, splice variants, and post-translational modifications can influence apparent specificity and potency.
- Matrix and sample effects: buffer composition, detergents, and biological matrices may alter stability or apparent activity; interpret with appropriate controls.
- Control concepts: include negative controls and orthogonal validation (e.g., genetic perturbation or alternative reagents) to support robust interpretation.
Can’t Find What You’re Looking For? We can help you source the best match or customize a recombinant protein solution for your study. Options may include species (human/mouse/rat), protein region/domain (full-length vs fragment), tag or label (His/GST/FLAG/biotin/fluorescent), expression system (E. coli/HEK293/insect), purity grade, formulation (buffer, carrier-free, glycerol-free), activity/functional validation (binding or enzymatic assays), endotoxin level (low-endotoxin for cell-based work), mutants/variants (point mutations, isoforms), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Di Fruscia, P.
et al. (2014) Bioorg. Med. Chem. Lett.24, 3974.
Roux, P.P. and Barker P.A.
(2002) Prog. Neurobiol. 67, 203.
Levi-Montalcini, R.
(1966) Harvey Lect. 60, 217.
Farinas, I.
et al. (1998) Neuron 21, 325.
Levi-Montalcini, R.
et al. (1996) Trends Neurosci. 19, 514.
Bradshaw, R.A.
(1978) Annu. Rev. Biochem. 47, 191.
Bocchini, V. and Angeletti, P.U.
(1969) Proc. Natl. Acad. Sci. U.S.A. 64, 787.
McDonald, N.Q.
et al. (1991) Nature 354, 411.
Huang, E.J. and Reichardt, L.F.
(2001) Annu. Rev. Neurosci. 24, 677.
Freund V. and Frossard, N.
(1994) Prog. Brain Res. 146, 335.
Raychaudhuri, S.P. and Raychaudhuri, S.K.
(2004) Prog. Brain Res. 146, 433.
Kawamoto, K. and Matsuda, H.
(2004) Prog. Brain Res. 146, 369.
Teng, K.K. and Hempstead, B.L.
(2004) Cell Mol. Life Sci. 61, 35.
Bocchini, V. and Angeletti, P.U.
(1969) Proc. Natl. Acad. Sci. U.S.A. 64, 787.
Huang, E.J. and Reichardt, L.F.
(2001) Annu. Rev. Neurosci. 24, 677.
